Purpose The University of Washington Self-Efficacy Scale (UW-SES) was originally developed for people with multiple sclerosis (MS) and spinal cord injury (SCI). This study evaluates the measurement invariance of the 6-item short form of the UW-SES across four disability subgroups. Evidence of measurement invariance would extend the UW-SES for use in two additional diagnostic groups: muscular dystrophy (MD) and post-polio syndrome (PPS). Methods Multi-group confirmatory factor analysis was used to evaluate successive levels of measurement invariance of the 6-item short form, the UW-SES: (a) configural invariance, i.e., equivalent item-factor structures between groups; (b) metric invariance, i.e., equivalent unstandardized factor loadings between groups; and (c) scalar invariance, i.e., equivalent item intercepts between groups. Responses from the four groups with different diagnostic disorders were compared: MD (n = 172), MS (n = 868), PPS (n = 225), and SCI (n = 242).
Introduction
Self-efficacy is the extent or strength of an individual's belief in his/her own ability to produce the desired effects of a task or activity [1] . Individuals with disabilities often report lower quality of life due to secondary conditions such as limitations in mobility, changes in bowel and bladder function, chronic pain, or ongoing medical complications [2] . These challenges may affect individuals' confidence in their ability to achieve desired goals, such as participating in meaningful relationships, promoting wellbeing, or managing health issues [3, 4] .
Several scales have been developed to measure self-efficacy for specific chronic diseases such as multiple sclerosis (MS) [5] , spinal cord injury (SCI) [6, 7] , MS or SCI [8] , epilepsy [9] , arthritis [10] , chronic disease in general [11] , or general self-efficacy [12] . While these scales have been developed for people with specific chronic diseases, a question remains whether the construct measured (i.e., selfefficacy) has the same meaning across groups with different chronic diseases [13, 14] . Thus, further investigation is needed to answer the question of whether the scale items perform similarly across subgroups with different chronic diseases. One way to examine this question is through assessing the measurement invariance of a scale.
Testing measurement invariance has been primarily conducted using two approaches: multi-group confirmatory factor analysis (MG-CFA) and item response theory (IRT). Similarities and differences between the two approaches have been investigated; a simulation study by Kim and Yoon [15] pointed out that both MG-CFA and IRT showed reasonable power to identify differential item functioning (DIF). Stark et al. [16] reported both the MG-CFA and IRT methods showed similar results in detecting DIF across a majority of simulated conditions. Specifically, the authors note that the MG-CFA approach performed slightly worse than the IRT approach in dichotomous data, while MG-CFA approach performed better with polytomous data. Moreover, the previous literature suggests that testing measurement invariance via the IRT approach is less preferable as the MG-CFA approach is more advanced, simpler, and more user-friendly than IRT [16, 17] .
A recently introduced self-efficacy measure called the University of Washington Self-Efficacy Scale (UW-SES) was developed for people living with MS and SCI [18] . The initial UW-SES development study investigated whether measurement invariance of UW-SES items existed between people with MS and SCI, using the IRT method, by detecting DIF. An absence of meaningful DIF between MS and SCI was found, indicating that the items performed similarly between the two groups [18] .
However, this scale has not yet been tested for measurement invariance across other diagnostic groups. Thus, the current study will extend the previous study by Amtmann et al. [18] by testing the measurement invariance of the 6-item short form of UW-SES across people with muscular dystrophy (MD) and post-polio syndrome (PPS). The evidence of measurement invariance would provide support for the construct of self-efficacy related to management of chronic conditions as measured by the UW-SES being the same in people with MD and PPS as in the people with MS and SCI. Establishing measurement invariance would allow users to attribute differences in self-efficacy scores to actual differences between groups. The previous literature supports the use of MG-CFA over IRT with polytomous items [16] . Thus, the current study employs the MG-CFA approach to test the existence of measurement invariance for the UW-SES.
Methods

Instruments
The UW-SES short form is a unidimensional instrument that includes 6 items developed for individuals with disabilities and chronic conditions. Responses to items are made on a five-point scale (1 = ''not at all,'' 2 = ''a little,'' 3 = ''quite a bit,'' 4 = ''a lot,'' and 5 = ''completely''); higher scores indicate higher self-efficacy. High reliability has been demonstrated for UW-SES with a Cronbach's alpha coefficient of .90 for the 6-item short form. Construct and discriminant validity have also been supported [18] . The items appear in Appendix 1. The concordance table appears in Appendix 2.
Participants
Two data sets obtained from different sources were pooled: (1) a longitudinal study of symptoms and quality-of-life indicators of persons with MS and (2) a longitudinal study investigating the role of secondary conditions in aging individuals with a disability. Previous publications have described recruitment procedures for the two studies in more detail [19] [20] [21] [22] . Briefly, study 1 participants were recruited through the Greater Washington chapter of the US National Multiple Sclerosis Society. Eligibility requirements included a self-reported diagnosis of MS, the ability to read and write English, being at least 18 years old, and providing written consent. While the baseline survey included 1271 subjects, a random subset of 584 subjects from the seventh time point (collected between June and December 2009) was used. The second data set (n = 923) was administered from July 2009 to April 2010 and required participants to have a self-reported diagnosis of MD, MS, PPS, or SCI; be able to read and write English; be at least 18 years old; and provide written consent. Recruitment strategies included advertisements in organization newsletters and Web sites (e.g., Muscular Dystrophy Foundation), invitation letters from the University of Washington registry of individuals with disabilities, and other specific condition registries (e.g., SCI Model Systems). The Institutional Review Board at the University of Washington, Seattle, reviewed and approved both studies' procedures.
Analysis
Three levels of measurement invariance were tested via MG-CFA. The first and weakest level, configural invariance, tests that the same pattern of item-factor loadings exists across the groups being compared, which requires that the same items have nonzero loadings on the same factors. The second and more constrained level, metric invariance, additionally requires that unstandardized factor loadings are the same across groups. Finally, scalar invariance, the most constrained model, requires meeting not only the assumptions of configural and metric invariance but also that unstandardized item thresholds be invariant across groups [14] . There is no consensus regarding the level of measurement invariance necessary to confidently compare scores across groups. In practice, either metric invariance or scalar invariance has been recommended as a prerequisite for group comparisons [23, 24] . Invariance models were estimated using Mplus software 7.0 [25] with a weighted least-squares mean and variance-adjusted estimation.
Goodness of fit was evaluated using v 2 , the comparative fit index (CFI), the Tucker-Lewis index (TLI), and the rootmean-square error of approximation (RMSEA). CFI and TLI assess the relative improvement in fit of the hypothesized model compared with a baseline model. Values above .95 are considered to indicate acceptable model fit [26] . RMSEA is a badness-of-fit index in that a value of 0 indicates the best fit and higher values indicate worse fit. Values less than .08 are considered to indicate adequate fit, and any values above .10 are considered to indicate poor fit [27] .
In the MG-CFA approach, the fit of a baseline model is compared to the fit of increasingly constrained models. The v 2 difference test is typically used to compare the fit of two nested models. When the v 2 difference is not statistically significant (i.e., the addition of constraining parameters does not significantly decrease model fit), researchers have evidence favoring the less parameterized model. However, the v 2 test statistic is inflated by sample size. Thus, other fit indexes are typically used to evaluate model fit with larger sample sizes [28] . As with the v 2 test statistic, the v 2 difference test is also sensitive to sample size. To account for this, we calculated the DCFI index. A difference of less than .01 in the DCFI index supports the less parameterized model. Model fit is compared only when both models of interest individually fit the data. (df = 15) = 66.135, p \ .001). There were no statistically significant differences among the groups in disease duration (F (3, 1462) = .410. 254, p = .746). In addition, we ran correlation analyses between each demographic variable and the UW-SES scale across the four groups. Given that the demographic variables were not substantially associated with UW-SES, we did not extend the current study to run the MG-CFA model to include demographic variables.
Measurement invariance
One-factor CFA with each of the 6 items loading onto the factor was modeled across the four groups and tested in this study. With the exception of the RMSEA statistic, the configural invariance models produced acceptable fit indexes, which supports configural invariance across the four diagnostic subgroups: v 2 (df = 69) = 393.127, p \ .001, CFI = .981, TLI = .983, and RMSEA = .112 (.101-.123). The metric invariance models also had good fit, with the exception of RMSEA: v 2 (df = 87) = 378.522, p \ .001, CFI = .983, TLI = .988, and RMSEA = .094 (.085-.104). The result of the v 2 difference test of model fit between the configural and metric invariance models was statistically significant: Dv Table 2 ).
Conclusion
The findings of the current study support configural, metric, and scalar invariance for the 6-item short form of UW-SES across the four diagnostic subgroups. The results of this study provide evidence that the measurement invariance requirement for valid group comparisons has been satisfied, and further suggest that self-efficacy, as measured by this scale, has the same meaning across the four subgroups. The findings of the current study also support the results of a previous study using DIF for meaningful group comparison in people with MS and SCI. Future studies should examine whether our results are supported using IRT approaches in comparing across the four different diagnostic groups. Comparing results based on MG-CFA, as used in the current study, and results based on the IRT method would extend our understanding of the level of measurement invariance for UW-SES items.
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6-Item short form summary score to T-score concordance All 6 items are summed as a first step. After summing, scores are transformed to a T-score metric using the concordance table provided above. For comparison purposes, the mean in the development sample was 49.9 with a SD of 9.3
